Synthesis and characterization of celecoxib derivatives as possible anti-inflammatory, analgesic, antioxidant, anticancer and anti-HCV agents. 2013

Ş Güniz Küçükgüzel, and İnci Coşkun, and Sevil Aydın, and Göknur Aktay, and Şule Gürsoy, and Özge Çevik, and Özlem Bingöl Özakpınar, and Derya Özsavcı, and Azize Şener, and Neerja Kaushik-Basu, and Amartya Basu, and Tanaji T Talele
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Marmara University, Haydarpaşa, 34668 İstanbul, Turkey. gkucukguzel@marmara.edu.tr

A series of novel N-(3-substituted aryl/alkyl-4-oxo-1,3-thiazolidin-2-ylidene)-4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamides 2a-e were synthesized by the addition of ethyl a-bromoacetate and anhydrous sodium acetate in dry ethanol to N-(substituted aryl/alkylcarbamothioyl)-4-[5-(4-methylphenyl)-3-(trifluoro-methyl)-1H-pyrazol-1-yl]benzene sulfonamides 1a-e, which were synthesized by the reaction of alkyl/aryl isothiocyanates with celecoxib. The structures of the isolated products were determined by spectral methods and their anti-inflammatory, analgesic, antioxidant, anticancer and anti-HCV NS5B RNA-dependent RNA polymerase (RdRp) activities evaluated. The compounds were also tested for gastric toxicity and selected compound 1a was screened for its anticancer activity against 60 human tumor cell lines. These investigations revealed that compound 1a exhibited anti-inflammatory and analgesic activities and further did not cause tissue damage in liver, kidney, colon and brain compared to untreated controls or celecoxib. Compounds 1c and 1d displayed modest inhibition of HCV NS5B RdRp activity. In conclusion, N-(ethylcarbamothioyl)-4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (1a) may have the potential to be developed into a therapeutic agent.

UI MeSH Term Description Entries
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D004487 Edema Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE. Dropsy,Hydrops,Anasarca
D005260 Female Females
D006614 Hindlimb Either of two extremities of four-footed non-primate land animals. It usually consists of a FEMUR; TIBIA; and FIBULA; tarsals; METATARSALS; and TOES. (From Storer et al., General Zoology, 6th ed, p73) Hindlimbs
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Ş Güniz Küçükgüzel, and İnci Coşkun, and Sevil Aydın, and Göknur Aktay, and Şule Gürsoy, and Özge Çevik, and Özlem Bingöl Özakpınar, and Derya Özsavcı, and Azize Şener, and Neerja Kaushik-Basu, and Amartya Basu, and Tanaji T Talele
January 2008, Journal of medicinal chemistry,
Ş Güniz Küçükgüzel, and İnci Coşkun, and Sevil Aydın, and Göknur Aktay, and Şule Gürsoy, and Özge Çevik, and Özlem Bingöl Özakpınar, and Derya Özsavcı, and Azize Şener, and Neerja Kaushik-Basu, and Amartya Basu, and Tanaji T Talele
June 2015, Journal of enzyme inhibition and medicinal chemistry,
Ş Güniz Küçükgüzel, and İnci Coşkun, and Sevil Aydın, and Göknur Aktay, and Şule Gürsoy, and Özge Çevik, and Özlem Bingöl Özakpınar, and Derya Özsavcı, and Azize Şener, and Neerja Kaushik-Basu, and Amartya Basu, and Tanaji T Talele
April 2024, Anti-cancer agents in medicinal chemistry,
Ş Güniz Küçükgüzel, and İnci Coşkun, and Sevil Aydın, and Göknur Aktay, and Şule Gürsoy, and Özge Çevik, and Özlem Bingöl Özakpınar, and Derya Özsavcı, and Azize Şener, and Neerja Kaushik-Basu, and Amartya Basu, and Tanaji T Talele
January 2017, Anti-cancer agents in medicinal chemistry,
Ş Güniz Küçükgüzel, and İnci Coşkun, and Sevil Aydın, and Göknur Aktay, and Şule Gürsoy, and Özge Çevik, and Özlem Bingöl Özakpınar, and Derya Özsavcı, and Azize Şener, and Neerja Kaushik-Basu, and Amartya Basu, and Tanaji T Talele
January 2015, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy,
Ş Güniz Küçükgüzel, and İnci Coşkun, and Sevil Aydın, and Göknur Aktay, and Şule Gürsoy, and Özge Çevik, and Özlem Bingöl Özakpınar, and Derya Özsavcı, and Azize Şener, and Neerja Kaushik-Basu, and Amartya Basu, and Tanaji T Talele
January 2019, Drug design, development and therapy,
Ş Güniz Küçükgüzel, and İnci Coşkun, and Sevil Aydın, and Göknur Aktay, and Şule Gürsoy, and Özge Çevik, and Özlem Bingöl Özakpınar, and Derya Özsavcı, and Azize Şener, and Neerja Kaushik-Basu, and Amartya Basu, and Tanaji T Talele
February 2008, Bioorganic & medicinal chemistry letters,
Ş Güniz Küçükgüzel, and İnci Coşkun, and Sevil Aydın, and Göknur Aktay, and Şule Gürsoy, and Özge Çevik, and Özlem Bingöl Özakpınar, and Derya Özsavcı, and Azize Şener, and Neerja Kaushik-Basu, and Amartya Basu, and Tanaji T Talele
May 2012, Archives of pharmacal research,
Ş Güniz Küçükgüzel, and İnci Coşkun, and Sevil Aydın, and Göknur Aktay, and Şule Gürsoy, and Özge Çevik, and Özlem Bingöl Özakpınar, and Derya Özsavcı, and Azize Şener, and Neerja Kaushik-Basu, and Amartya Basu, and Tanaji T Talele
February 2003, Journal of enzyme inhibition and medicinal chemistry,
Ş Güniz Küçükgüzel, and İnci Coşkun, and Sevil Aydın, and Göknur Aktay, and Şule Gürsoy, and Özge Çevik, and Özlem Bingöl Özakpınar, and Derya Özsavcı, and Azize Şener, and Neerja Kaushik-Basu, and Amartya Basu, and Tanaji T Talele
July 2006, Archiv der Pharmazie,
Copied contents to your clipboard!